RT Journal Article
T1 Recommendation for Presbyopia-Correcting Intraocular Lenses: A Delphi Consensus Statement by the ESASO Study Group
A1 Romano, Vito
A1 Madrid Costa, David
A1 Alfonso. Jose F., 
A1 Alio, Jorge
A1 Allan, Bruce
A1 Angunawela., Romesh
A1 Auffarth, Gerd
A1 Carones, Franceso
A1 Khoramnia, Ramin
A1 Moore, Johnny
A1 Nanavaty ; Mayanka, 
A1 Savini, Giacomo
A1 Pagano, Luca
A1 Romano, Mario R.
A1 Virgili, Gianni
A1 Fernández Vega-Cueto, Luis
A1 Madrid Costa, David
AB Purpose: To establish consensus among experts in lens and refractive surgery to guide general ophthalmologists on issues related to presbyopia-correcting intraocular lenses (IOLs).Design: A modified Delphi method to reach a consensus among experts.Methods: A steering committee formulated 105 relevant items grouped into four sections (preoperative considerations, IOL selection, intraoperative considerations, and postoperative considerations). The consensus was defined as ≥ 70% of experts agreeing with the evaluation of a statement.Results: Ten experts participated and completed all rounds of questionnaires (100% response rate). Of 68 items considered in the preoperative considerations, consensus was achieved in 48 (70.6%). There was a lack of consensus over IOL selection, the experts only agreed on the importance of the patient's habits for the optical IOL design selection. Of the 14 considerations related to intraoperative issues, the experts reached a consensus on 10 (71.4%). The postoperative considerations section reached the highest consensus in 10 items of 13 (76.9%).Conclusions: Key recommendations for a diffractive multifocal IOL were a potential postoperative visual acuity > 0.5, a keratometry between 40-45 diopters, a pupil >2.8 mm under photopic conditions and <6.0 mm under scotopic conditions, a root mean square of higher order corneal aberrations <0.5 µm for 6-mm pupil size, while monofocal or non-diffractive IOLs should be considered for patients with coexisting eye disorders. A lack of agreement was found in the issues related to the IOL selection.
PB Elsevier
SN 0002-9394
YR 2023
FD 2023-06-20
LK https://hdl.handle.net/20.500.14352/91908
UL https://hdl.handle.net/20.500.14352/91908
LA eng
DS Docta Complutense
RD 16 may 2025